Scientists have developed an innovative form of eye drops that may help stop tumour growth in the retina while preserving vision, according to new research.
The study, conducted on laboratory animals, showed that subjects treated with the drops experienced reduced tumour growth along with better eyesight compared to untreated cases.
The treatment uses microscopic particles designed to deliver cancer-fighting molecules directly into the eye. These particles are able to penetrate natural barriers in the eye, allowing targeted treatment without damaging healthy tissue.
Researchers believe this approach could offer a less invasive alternative to current treatments such as injections, laser therapy and chemotherapy, which can also affect healthy parts of the eye.
Early safety tests have shown encouraging results, with minimal side effects reported during short-term use. However, experts caution that the findings are still in early stages, and further research is needed to confirm long-term safety and effectiveness in humans.
If proven successful, the method could provide a safer and more comfortable treatment option for retinal cancers in the future.
